【摘 要】
：
Objectives: The objective of this systematic review and meta-analysis was to estimate the effectiveness of problem-based learning in developing nursing students critical thinking.
【出 处】
：
中华医学会第五次全国病毒性肝炎慢性化、重症化基础与临床研究进展学术会议
论文部分内容阅读
Objectives: The objective of this systematic review and meta-analysis was to estimate the effectiveness of problem-based learning in developing nursing students critical thinking.
其他文献
Background & Aims: The pattern of cytokines in sera was consistent with the level of inflammation during chronic hepatitis.By observing the difference of cytokines expression between HBeAg-positive an
目的:探讨恩替卡韦联合细胞因子诱导的杀伤细胞(CIK)治疗HBeAg阳性慢性乙型肝炎(CHB)的临床疗效及安全性.方法:收集50例HBeAg阳性CHB患者,其中治疗组20例,采用恩替卡韦联合CIK治疗,对照组30例,单用恩替卡韦治疗.观察所有患者治疗前及治疗后第12、24、48周肝功能、HBV血清标志物和HBV DNA水平并进行统计学分析,同时对不良反应进行评估.
目的:本研究探讨CTLA4+49G/A位点基因多态性与HBV感染慢性化及乙肝相关肝癌的相关性,并了解慢乙肝及肝癌患者Th1/Th2平衡状态.方法:应用基因测序方法对HBV相关肝癌患者154例,慢性乙型肝炎患者199例,HBV自限性感染患者232例的CTLA4基因+49G/A位点进行检测,分析此多态性与慢性乙型肝炎及乙肝相关HCC之间的关系;同时对患者外周血单个核细胞(PBMCs)经梯度密度离心法分
Background and Aims: Chronic liver failure (CLIF)-SOFA score was introduced to the diagnostic criteria for acute-chronic liver failure (ACLF) in recent by the European Association for The Study of Liv
Background: To investigate thyroid function in patients with acute-on-chronic liver failure (ACLF) caused by hepatitis B virus infection and to determine whether thyroid hormone levels can be used as
目的:评估干扰素应答不佳(Poor interferon response PIR)的HBeAg阳性慢性乙型肝炎(HBeAg-positive chronic hepatitis B,E+CHB)患者序贯替比夫定(LDT)的临床疗效及安全性.方法:开放性、前瞻性队列研究.纳入36例符合2010年中国《慢性乙肝防治指南》诊断标准的E+CHB,患者连续使用聚乙二醇干扰素≥24周,并满足以下条件之一:H
目的:评价血清病毒学标记物预测慢性乙型肝炎(CHB)肝组织病理状态的有效性.方法:CHB患者211例,其中HBeAg阳性和阴性患者分别为125例和86例.血清HB-sAg、HBeAg、抗-HBc和HBcrAg分别采用化学发光微粒子免疫法和化学发光酶免疫法检测,血清HBV DNA采用实时荧光定量PCR检测.
Objective: Most symptoms of HCV patients are mild or even absent due to insufficient inflammatory initiation.Clinically, Anti-HCV responses often accompanied with an increase of ALT level while HCV-in
背景与目的:非活动性HBsAg携带者(Inactive hepatitis S antigen carries,IHC)表现为:HBsAg阳性,HBeAg阴性/抗-HBe抗体阳性,HBV DNA载量较低或检测不到,肝功能正常,这类患者通常被认为处于"免疫控制状态",但却并非临床治愈,仍存危害.
目的:核苷(酸)类似物(nueleotide and nucleotide analogs,NAs)治疗应答不佳/耐药的慢性乙型肝炎(Chronic hepatitis B,CHB)患者,采用聚乙二醇干扰素(peginterferon,Peg-IFN)+NAs和NAs+NAs两种联合治疗,比较疗效,探求具有停药终点的优化治疗方案.